Early ACTID

The Early ACTivity In Diabetes (Early ACTID) Study, run by the University of Bristol, was designed to assess the benefits of diet and exercise for people with early diagnosed type 2 diabetes. Exercise and diet are thought to be important factors in the treatment of the disease. Researchers know diet can control glucose levels and improve blood pressure and cholesterol in people with diabetes, but little is known about how, or if, exercise affects these factors.

Study participants were allocated to one of the three groups. The first group received regular help and advice on improving their diet, the second group received the same dietary advice, but also received help to increase their daily levels of exercise. The final group, the control group, received standard care.

Participants were seen at their most local hospital. Hospitals involved in the study include Musgrove Park, Taunton; Weston General, Weston-super-Mare; the BRI, Southmead and Frenchay, Bristol; Delancey, Cheltenham and Gloucester hospitals.

The programme was a joint study between three departments at the University of Bristol. Dr's Robert Andrews and Colin Dayan from Henry Wellcome Laboratories for Integrative Neuroscience and Endocrinology, Dr Ashley Cooper in the Department of Exercise and Health Sciences, and Dr Alan Montgomery and Professors Tim Peters and Debbie Sharp in Primary Health Care.

The Early ACTID Study was launched in November 2004 and completed in September 2009, with an impressive 593 participants being randomised in the trial. The Early ACTID follow-up study has now commenced and is hoping to re-recruit all the participants from the Early ACTID Study.

 

Patient information sheet